Unlock the Next Generation of Immunology Therapeutics: Inside the STAT6 PROTAC Discovery Platform
Discover how BioDuro’s expert team synthesized STAT6 PROTACs from patent blueprints, validated degradation across immune cells, and built a cutting-edge screening platform in record time. This whitepaper unveils a new frontier in drug development—where transcription factors once deemed “undruggable” are now within reach.
Whether you're in early discovery or lead optimization, this report will show how targeted protein degradation is transforming therapeutic strategies for inflammatory diseases like atopic dermatitis and asthma.
Get the exclusive insights. Download your copy now.
|
|
| |
|
|
